Key Takeaways
- Neonatal abstinence syndrome is a treatable medical condition, not a reflection of parental worth or capacity
- The eat, sleep, console model has replaced the Finnegan scoring system in many hospitals, reducing pharmacological treatment and NICU admissions
- Nonpharmacological interventions including skin-to-skin contact, swaddling, breastfeeding, and environmental modification are first-line NAS treatments
- Most infants with NAS achieve normal developmental milestones when provided consistent caregiving and appropriate follow-up
- Parental presence and involvement during NAS treatment significantly improves infant outcomes and shortens hospital stays
- Trust SoCal provides integrated maternal recovery and NAS family support services in Orange County at (949) 280-8360
Understanding Neonatal Abstinence Syndrome
Neonatal abstinence syndrome occurs when a newborn who was exposed to addictive substances in utero experiences withdrawal symptoms after birth. The condition most commonly results from prenatal opioid exposure, whether from illicit opioid use or medication-assisted treatment with methadone or buprenorphine. NAS affects approximately 7 out of every 1,000 hospital births in the United States, with incidence rates varying significantly by region and having increased fivefold between 2004 and 2014 according to the National Institute on Drug Abuse.
Understanding NAS as a medical condition rather than a moral failing is essential for both parents and healthcare providers. Infants who develop NAS are not damaged or destined for poor outcomes. With appropriate medical management, family support, and follow-up care, most NAS-affected infants achieve normal developmental trajectories. At Trust SoCal in Fountain Valley, California, we help parents understand NAS within the context of their recovery journey, providing education and emotional support alongside addiction treatment.
NAS is a treatable, temporary medical condition. The majority of infants with NAS recover fully and achieve typical developmental milestones. If your baby has been diagnosed with NAS, remember that seeking treatment during pregnancy was a responsible, protective choice. Contact Trust SoCal at (949) 280-8360 for family support services.
How NAS Develops
During pregnancy, most substances cross the placental barrier and reach the developing fetus. When opioids are present consistently throughout gestation, the fetal nervous system adapts to their presence, developing physiological dependence. After birth, when the umbilical supply of opioids is severed, the newborn's nervous system must readjust to functioning without the substance, producing withdrawal symptoms that constitute NAS.
- NAS symptoms typically appear within 24 to 72 hours of birth for short-acting opioids and up to 5 to 7 days for methadone or buprenorphine
- The severity and duration of NAS depend on the type of opioid, dose, duration of exposure, infant metabolism, and gestational age
- Polysubstance exposure, particularly concurrent benzodiazepine or SSRI use, can modify NAS presentation and timeline
Signs and Symptoms Parents Should Know
NAS symptoms affect the central nervous system, autonomic nervous system, and gastrointestinal tract. Parents who understand these symptoms are better equipped to participate in their infant's care, communicate with medical staff, and distinguish normal newborn behavior from withdrawal-related distress. Not all symptoms will be present in every infant, and severity ranges from mild to requiring pharmacological intervention.
- Central nervous system symptoms include high-pitched crying, tremors, increased muscle tone, irritability, and disturbed sleep patterns
- Gastrointestinal symptoms include poor feeding, excessive sucking, vomiting, diarrhea, and failure to gain weight appropriately
- Autonomic symptoms include sneezing, yawning, sweating, fever, and mottled skin coloring
Substances That Cause NAS
While opioids are the most common cause of NAS, other substances can produce neonatal withdrawal syndromes. Benzodiazepines, barbiturates, alcohol, and SSRIs can all cause postnatal withdrawal symptoms, though the clinical presentation and management differ from opioid-related NAS. Polysubstance exposure creates more complex withdrawal patterns that may require longer observation periods and more intensive management.
- Opioids including heroin, fentanyl, oxycodone, methadone, and buprenorphine are the primary causes of classical NAS
- Benzodiazepine withdrawal in newborns can produce seizures and requires specialized monitoring distinct from opioid NAS
- SSRI discontinuation syndrome in newborns is generally mild and self-limiting but can mimic some NAS symptoms
Hospital Assessment and Scoring Systems
Accurate assessment of NAS severity guides treatment decisions and determines the intensity of care required. For decades, the modified Finnegan Neonatal Abstinence Scoring System was the standard assessment tool, using a 31-item checklist scored every 3 to 4 hours to quantify withdrawal severity. However, the field has increasingly moved toward the eat, sleep, console approach, which prioritizes functional assessment over symptom enumeration and has been associated with reduced pharmacological treatment and shorter hospital stays.
Understanding how your infant is being assessed helps parents engage meaningfully in care discussions and advocate for evidence-based practices. At Trust SoCal, we prepare parents for the NAS assessment process during prenatal counseling, explaining both the Finnegan system and the eat, sleep, console model so that families feel informed and empowered regardless of which approach their delivery hospital employs.
The Finnegan Scoring System
The modified Finnegan Neonatal Abstinence Scoring System assigns numerical values to 31 withdrawal signs across central nervous system, metabolic, vasomotor, respiratory, and gastrointestinal domains. Scores are calculated every 3 to 4 hours by nursing staff. Three consecutive scores above 8, or two consecutive scores above 12, typically trigger initiation of pharmacological treatment. While widely used, the Finnegan system has been criticized for inter-rater variability, observer disruption of sleeping infants, and potentially overestimating NAS severity.
- Finnegan scores range from 0 to 46, with scores above 8 suggesting moderate to severe withdrawal
- Assessments require waking and handling the infant, which can paradoxically increase irritability and inflate scores
- Inter-rater reliability varies significantly across nursing staff, even with training and standardization efforts
The Eat, Sleep, Console Model
The eat, sleep, console (ESC) model represents a paradigm shift in NAS assessment and management. Rather than cataloging and scoring individual symptoms, ESC asks three functional questions: can the infant eat at least one ounce or breastfeed effectively, can the infant sleep for at least one hour undisturbed, and can the infant be consoled within 10 minutes of onset of distress. This approach prioritizes nonpharmacological interventions and parental involvement, reserving medication for infants who cannot achieve functional goals despite optimal environmental and caregiving support.
- Hospitals implementing ESC have reported 50 to 70 percent reductions in pharmacological treatment for NAS
- Average hospital stays under ESC are 6 to 10 days shorter compared to Finnegan-based management
- ESC empowers parents as primary caregivers rather than passive observers, strengthening early bonding
What Parents Can Expect During Assessment
Regardless of the scoring system used, parents should expect regular assessment of their infant for at least 72 to 96 hours after birth, with longer observation for methadone-exposed infants. Assessment involves observation of the infant's state, feeding patterns, sleep quality, and consolability. Parents play a crucial role in this process by reporting their observations of the infant's behavior between formal assessments and participating actively in nonpharmacological comfort measures.
- Expect a minimum hospital stay of 4 to 7 days for observation, even if NAS symptoms are mild or absent
- Ask your medical team which assessment model they use and request explanation of scoring criteria
- Keep a log of your infant's feeding amounts, sleep duration, and episodes of inconsolability to share with the care team
Nonpharmacological Treatment: The First Line of Care
Nonpharmacological interventions are the foundation of NAS management and should be maximized before pharmacological treatment is considered. These interventions leverage the neurobiological calming systems activated by skin-to-skin contact, rhythmic movement, environmental modification, and responsive caregiving. Research consistently demonstrates that optimal nonpharmacological care reduces NAS severity, decreases the need for medication, and shortens hospital stays.
Parents are the most powerful nonpharmacological intervention available to NAS-affected infants. Maternal and paternal presence, touch, voice, and feeding provide sensory regulation that no medical device or protocol can replicate. Trust SoCal emphasizes parental empowerment in NAS care, helping mothers and fathers understand that their active involvement is not just helpful but is medically therapeutic for their infant.
The single most effective nonpharmacological intervention for NAS is skin-to-skin contact between parent and infant. Ask your hospital team about kangaroo care, where your infant rests against your bare chest. Studies show this reduces crying, stabilizes heart rate and temperature, promotes breastfeeding, and decreases NAS severity scores.
Skin-to-Skin Contact and Kangaroo Care
Kangaroo care, extended skin-to-skin contact between parent and infant, activates multiple neurobiological soothing pathways simultaneously. Thermal regulation from the parent's body, the auditory familiarity of the maternal heartbeat, vestibular stimulation from respiratory movement, and olfactory recognition of the parent all contribute to reduced stress hormone levels and improved state regulation in the newborn. For NAS-affected infants, these effects are particularly pronounced and clinically significant.
- Skin-to-skin contact reduces cortisol levels in both parent and infant, creating a bidirectional calming effect
- Infants receiving at least 4 hours daily of kangaroo care show significantly lower Finnegan scores than those without
- Skin-to-skin contact promotes successful breastfeeding initiation, which independently reduces NAS severity
Environmental Modification and Sensory Regulation
NAS-affected infants have heightened sensitivity to environmental stimuli including light, sound, and movement. Creating a low-stimulation environment reduces nervous system arousal and helps the infant maintain a calm, organized behavioral state. Simple modifications to the hospital environment and later the home environment can significantly reduce withdrawal symptom expression and improve infant comfort.
- Dim lighting, reduced noise levels, and minimal unnecessary handling create a low-stimulation recovery environment
- Tight swaddling with arms contained provides proprioceptive input that reduces tremors and startling
- White noise machines or gentle rhythmic sounds can help mask disruptive environmental noises that trigger irritability
Feeding Support and Nutritional Considerations
NAS-affected infants often require additional caloric intake to compensate for the increased metabolic demands of withdrawal. Poor feeding coordination, excessive sucking, vomiting, and diarrhea can compound nutritional challenges. Demand feeding, high-calorie formula supplementation when needed, and careful monitoring of weight gain are essential components of NAS nutritional management. Breastfeeding, when appropriate, provides both nutritional and nonpharmacological benefits.
- Small, frequent feedings of 1 to 2 ounces every 2 to 3 hours often work better than larger, less frequent feeds for NAS infants
- High-calorie formula at 22 to 24 calories per ounce may be recommended if weight gain is inadequate on standard feeds
- Slow-flow nipples and paced feeding techniques help NAS infants with suck-swallow coordination difficulties
Pharmacological Treatment When Needed
Despite optimal nonpharmacological care, approximately 50 to 60 percent of opioid-exposed newborns require pharmacological treatment for NAS. Medication is initiated when the infant cannot eat, sleep, or be consoled adequately despite comprehensive nonpharmacological support, or when Finnegan scores consistently exceed treatment thresholds. The goal of pharmacological treatment is to control withdrawal symptoms sufficiently to allow feeding, growth, and bonding while gradually tapering the medication as the infant's nervous system stabilizes.
Understanding that your infant may need medication and that this represents appropriate medical care rather than failure helps parents maintain emotional equilibrium during what can be a stressful hospitalization. The medications used to treat NAS are safe, well-studied, and administered with careful dose titration and monitoring. Trust SoCal helps parents understand these treatment protocols through our prenatal education programming and ongoing family support during hospitalization.
If your infant requires pharmacological treatment for NAS, this is not a reflection of your choices or your parenting. It is a standard medical intervention used when nonpharmacological measures alone are insufficient. Your continued presence, skin-to-skin contact, and feeding involvement remain essential therapeutic components alongside medication.
First-Line Medications for NAS
Morphine has traditionally been the most widely used first-line medication for opioid-related NAS. Administered orally in small, weight-based doses, morphine controls withdrawal symptoms while allowing gradual tapering. More recently, buprenorphine sublingual formulations have emerged as an alternative first-line treatment with evidence suggesting faster time to NAS resolution and shorter hospital stays. Methadone is another option, particularly for infants exposed to methadone in utero.
- Oral morphine solution is dosed based on infant weight and adjusted every 24 to 48 hours based on symptom control
- Sublingual buprenorphine has shown 40 percent shorter treatment durations compared to oral morphine in clinical trials
- Clonidine may be used as an adjunctive agent for infants with symptoms refractory to opioid monotherapy
Tapering Protocols and Treatment Duration
Once the infant is stabilized on medication, a gradual tapering protocol begins. Dose reductions of 10 to 20 percent every 24 to 48 hours are typical, guided by ongoing assessment of withdrawal symptom control. The total duration of pharmacological treatment varies widely, from 5 to 7 days for mild cases to 4 to 8 weeks for severe NAS. Discharge typically occurs once the infant has been stable for 24 to 48 hours after the final dose reduction.
- Weaning proceeds based on clinical response rather than rigid schedules, with flexibility for individual infant needs
- Some hospitals discharge infants on tapering medication with close outpatient follow-up to shorten hospitalization
- Rebound symptoms during tapering may require temporary dose increases followed by a slower reduction schedule
Monitoring During Treatment
Infants receiving pharmacological treatment for NAS require regular monitoring of vital signs, feeding adequacy, weight gain, and medication side effects. Respiratory monitoring is particularly important during opioid therapy, though the risk of respiratory depression at therapeutic NAS treatment doses is very low. Parents should be educated on monitoring signs to watch for and encouraged to report any concerns to nursing staff promptly.
- Continuous pulse oximetry is standard during opioid treatment to monitor respiratory status
- Daily weight measurements track growth trajectory and feeding adequacy during treatment
- Parents should report any changes in breathing patterns, excessive sedation, or feeding refusal immediately
Bonding with Your Baby During NAS Treatment
Maintaining and strengthening the parent-infant bond during NAS hospitalization is both a developmental priority for the infant and a therapeutic necessity for parents in recovery. NAS-affected infants are often irritable, difficult to console, and resistant to handling, which can be intensely distressing for parents who already carry guilt about their substance use during pregnancy. Understanding that withdrawal-related irritability is a temporary medical symptom rather than rejection helps parents persist in their bonding efforts.
Research consistently shows that parental involvement during NAS hospitalization improves infant outcomes across every measured domain. Infants whose parents are present and actively involved in care require less medication, have shorter hospital stays, and demonstrate better feeding and growth patterns. For parents in recovery, active participation in their infant's NAS care can be a transformative experience that strengthens recovery motivation and builds parenting confidence.
Responding to a Difficult-to-Console Infant
NAS-affected infants may cry inconsolably despite parents' best efforts. This is one of the most challenging aspects of the NAS experience for families. Developing a repertoire of soothing strategies and understanding that some periods of crying are expected despite optimal care helps parents manage their emotional responses. The 5 S's method developed by Dr. Harvey Karp, incorporating swaddling, side or stomach position, shushing, swinging, and sucking, provides a structured approach to infant soothing.
- Tight swaddling with gentle rocking in a dimly lit, quiet environment is often the most effective soothing combination
- Taking turns between caregivers prevents burnout and maintains the patience needed for extended soothing episodes
- It is acceptable and important to place the infant safely in the crib and take a brief break when parental frustration peaks
Participating in Daily Care Routines
Every diaper change, feeding, and bathing interaction is an opportunity for bonding and developmental support. Parents should aim to perform as much of their infant's daily care as possible, even in the hospital setting. These routine caregiving interactions build parental competence and confidence while providing the infant with consistent sensory exposure to their primary attachment figures.
- Request to be included in all feeding, bathing, and diaper changing activities during the hospital stay
- Speak and sing to your infant during caregiving interactions to promote voice recognition and auditory development
- Infant massage techniques taught by nursing staff or occupational therapists can reduce NAS symptoms and enhance bonding
Managing Parental Guilt and Emotional Distress
Watching your infant experience NAS withdrawal symptoms is emotionally devastating for most parents. Feelings of guilt, shame, inadequacy, and grief are nearly universal and can threaten recovery stability if not addressed therapeutically. Trust SoCal provides individual and group therapy for parents navigating the NAS experience, helping them process these emotions while maintaining recovery and building the positive parental identity essential for their child's long-term wellbeing.
- Guilt about NAS is natural but should not become a barrier to bonding or a trigger for relapse
- Therapy focused on self-compassion and reparative parenting helps mothers reframe their narrative from failure to resilience
- Peer support from other parents who have navigated NAS provides validation and practical coping strategies
Discharge Planning and Taking Your Baby Home
Discharge from the hospital after NAS treatment marks a significant transition that requires careful planning. Parents need to feel confident in their ability to feed, soothe, and monitor their infant at home. Medical follow-up appointments must be scheduled, medication tapering protocols understood if outpatient weaning is planned, and home environments prepared with appropriate safety measures and sensory modifications.
Trust SoCal's family support team assists with discharge planning by coordinating between the hospital NICU or nursery team, the infant's pediatrician, and the parent's addiction treatment providers. This coordination ensures that no aspect of care falls through the cracks during the critical transition from hospital to home. Our goal is for every family to leave the hospital feeling prepared, supported, and connected to the ongoing resources they need.
If you are concerned about your infant's breathing, feeding, or behavior after hospital discharge, contact your pediatrician immediately. For medical emergencies, call 911. For parenting support and recovery assistance, call Trust SoCal at (949) 280-8360 or the Postpartum Support International helpline at 1-800-944-4773.
Home Environment Preparation
Preparing the home environment for a NAS-affected infant involves creating a calm, low-stimulation space that supports continued recovery from withdrawal. Infants discharged after NAS treatment may remain more sensitive to environmental stimuli than their unexposed peers for several weeks to months. Thoughtful environmental design reduces infant distress and makes caregiving more manageable during this transition period.
- Create a dedicated quiet sleeping space with blackout curtains, consistent temperature between 68 and 72 degrees, and minimal visual stimulation
- Stock multiple types of pacifiers and swaddling blankets to determine your infant's preferences
- Minimize visitors and household noise during the first two to four weeks at home to reduce sensory overload
Follow-Up Care and Monitoring Schedule
Infants discharged after NAS treatment require close pediatric follow-up to monitor growth, feeding, developmental milestones, and any residual or rebound withdrawal symptoms. The typical follow-up schedule includes a pediatric visit within 48 to 72 hours of discharge, weekly visits for the first month, and then monthly visits through six months of age. Developmental screening at regular intervals ensures early identification of any concerns.
- Schedule the first pediatric visit within 48 to 72 hours of hospital discharge
- Weight checks at each visit monitor nutritional adequacy and growth trajectory
- Developmental screening using the ASQ-3 should occur at 4, 8, 12, 18, and 24 months of age
Coordinating Parental Recovery with Infant Care
Balancing active addiction treatment participation with the demands of caring for a NAS-affected infant requires logistical planning and support. Treatment appointments, MAT dosing schedules, therapy sessions, and support group meetings must be coordinated with infant feeding times, pediatric appointments, and nap schedules. Trust SoCal works with each family to build a realistic, sustainable schedule that supports both parental recovery and infant care.
- Identify at least two trusted caregivers who can provide infant care during treatment appointments
- Communicate your infant care needs to your treatment team so scheduling can accommodate feeding and medical appointments
- Telehealth therapy options can reduce travel time and childcare needs while maintaining treatment engagement
Long-Term Developmental Outcomes for NAS-Affected Children
Parents naturally worry about the long-term effects of prenatal substance exposure and neonatal withdrawal on their child's development. Current research offers a largely reassuring picture when NAS-affected children receive consistent, responsive caregiving and appropriate developmental support. While some studies identify subtle differences in executive function, attention regulation, and school readiness, the caregiving environment exerts a far stronger influence on developmental outcomes than prenatal exposure alone.
The quality of the parent-child relationship, the stability of the home environment, and access to early intervention services when needed are the most powerful predictors of long-term outcomes for children with a history of NAS. This understanding should empower parents in recovery: your sobriety, your treatment engagement, and your attentive parenting are the most important factors determining your child's developmental trajectory.
What Research Shows About Developmental Outcomes
Longitudinal studies of children with NAS history show that the majority achieve normal cognitive, motor, and language milestones. A systematic review published in Pediatrics found that while prenatal opioid exposure is associated with small decrements in some cognitive and motor scores in early childhood, these differences diminish over time and are heavily moderated by environmental quality. Importantly, these studies often cannot separate the effects of substance exposure from the effects of associated risk factors such as poverty, trauma, and disrupted caregiving.
- Most NAS-affected children score within normal ranges on standardized developmental assessments by school age
- Environmental enrichment, responsive caregiving, and early intervention can offset subtle developmental effects of prenatal exposure
- Adoption and foster care studies demonstrate that improved caregiving environments dramatically improve outcomes for opioid-exposed children
Early Intervention Services
Early intervention services are available in every state under the Individuals with Disabilities Education Act Part C for children from birth to age three who have or are at risk for developmental delays. NAS history qualifies children for automatic eligibility in many states, including California. These services, which may include occupational therapy, speech therapy, and developmental support, are provided at no cost to families and can be accessed through regional centers.
- California's Regional Center system provides early intervention evaluations and services at no cost for eligible infants
- Referral to early intervention can be made by parents, pediatricians, or other providers without requiring a formal diagnosis
- Services are provided in the child's natural environment, typically the home, reducing logistical barriers for families in recovery
Building Resilience Through Responsive Parenting
The concept of developmental resilience, the capacity to achieve positive outcomes despite early adversity, is central to understanding NAS prognosis. Responsive, consistent parenting is the single most powerful resilience-promoting factor identified in developmental science. Parents who maintain recovery, engage in attachment-promoting interactions, and create stable home environments provide the conditions that allow their children to thrive regardless of early exposure history.
- Secure attachment to a consistent caregiver is the strongest protective factor against adverse developmental outcomes
- Parents in stable recovery demonstrate parenting quality comparable to non-substance-affected parents in longitudinal studies
- Reading, talking, and playing with your infant daily promotes neural development that supports long-term cognitive outcomes
Trust SoCal NAS Family Support Services
Trust SoCal provides comprehensive family support services for parents navigating neonatal abstinence syndrome at our Fountain Valley, Orange County facility. Our NAS family programming integrates parental addiction treatment with infant-focused education, bonding support, and care coordination to ensure that families receive unified, consistent support throughout the NAS experience and beyond.
Our clinical team recognizes that NAS is a family experience, not just a neonatal medical event. The emotional, logistical, and relational demands of managing an infant's NAS treatment while maintaining personal recovery require specialized support that addresses both dimensions simultaneously. Trust SoCal's integrated model provides this support, helping families build the foundation for healthy parent-child relationships and sustained recovery.
Trust SoCal offers a specialized NAS Family Education Program that prepares parents for the NAS experience before delivery and provides ongoing support during hospitalization and after discharge. Contact us at (949) 280-8360 to learn more. For immediate emotional support during your infant's NAS treatment, contact Postpartum Support International at 1-800-944-4773 or the 988 Suicide & Crisis Lifeline.
Prenatal NAS Education and Preparation
Trust SoCal's NAS preparation begins during prenatal treatment. Parents receive detailed education about what to expect during and after delivery, NAS signs and symptoms, hospital assessment and treatment protocols, and their role in nonpharmacological care. This preparation reduces anxiety, sets realistic expectations, and empowers parents to be active participants in their infant's care from the first moments of life.
- Prenatal NAS education sessions cover symptoms, treatment protocols, bonding strategies, and parental coping skills
- Hospital birth plan development includes NAS-specific preferences for assessment, rooming-in, and breastfeeding
- Connection with parents who have previously navigated NAS provides peer mentoring and emotional preparation
Hospital Liaison and Advocacy
During the infant's hospitalization for NAS, Trust SoCal clinical staff serve as liaison between the family and hospital team. This coordination ensures that the mother's recovery needs are communicated to hospital staff, that breastfeeding support is provided consistently, and that discharge planning integrates parental treatment schedules. Having an advocate who understands both addiction treatment and neonatal care reduces the fragmentation that families commonly experience.
- Trust SoCal staff communicate directly with hospital social work and neonatal teams on behalf of enrolled families
- Breastfeeding support and MAT coordination continue seamlessly during the hospital stay
- Advocacy for evidence-based practices including rooming-in and eat, sleep, console assessment is provided when needed
Postdischarge Family Support
After hospital discharge, Trust SoCal continues to support families through the transition home and beyond. Ongoing individual therapy, parenting groups, recovery programming, and care coordination help parents maintain recovery stability while meeting the demanding needs of a post-NAS infant. Quarterly developmental check-ins and connection with community resources such as early intervention services and pediatric follow-up ensure comprehensive, long-term family support.
- Weekly check-in calls during the first month home provide early identification of emerging challenges
- Parenting groups for NAS families offer peer support and evidence-based parenting skills training
- Connection with California Regional Center for early intervention evaluation and services is facilitated for all NAS-affected infants
Medical Review Board, MD, ABAM
Medical Director & Reviewer
